141 / 464
INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG
141
Programme and Exhibition Guide |
SCIENTIFIC PROGRAMME
MONDAY 8 MAY 2017
SYMPOSIUM
Lunch symposium - New journals phiRO, ctRO, tipsRO - Meet the
editors
13:00 - 14:45 | LEHAR 5
Chair: K. Røe Redalen (Norway)
Chair: P. Franco (Italy)
13:00 > How to write a good paper - Editor’s view
Speaker: L.P. Muren (Denmark)
13:10 > How to do a good paper review - Editor’s view
Speaker: D. Zips (Germany)
13:20 > How to make a paper high impact - Editor’s view
Speaker: S. Faithfull (UK)
13:30 > The scholarly publishing cycle and open access publishing
Speaker: S. Jenkins (The Netherlands)
13:50 > Questions from the audience
14:15 > Meet the editors (individual slots with sign-up)
SYMPOSIUM
Non-rectal GI tumours: key open questions to be answered from (and
for) the radiation oncologist!
14:45 - 16:15 | AUDITORIUM
This session will focus on key questions in oesophageal, pancreatic and anal cancer.
M. Hulshof will cover topics such as optimal radiotherapy dose and schedule in
different treatment settings. Following, the lecture will expand on non-conventional
tumour volume margin prescription and the importance of fiducials for accurate
targeting. E. Fokas will discuss the rationale for radiotherapy in the context of R1-
resection and local failure in pancreatic cancer, its controversial role, the neoadjuvant
concept and what will take to “salvage” radiotherapy in the disease. Finally, R.
Muirhead will give an overview on the current treatment options in anal cancer, the
advances in radiotherapy technique and imaging, toxicity and future dose escalation/
de-escalation trials.
Chair: E. Fokas (Germany)
Co-chair: J. Lövey (Hungary)
14:45 > Radio(chemo)therapy in oesophageal cancer: can we do better?
Speaker: M. Hulshof (The Netherlands)
SP-0469
15:15 > Does radiotherapy still have a role in the management of pancreatic
cancer?
Speaker: E. Fokas (Germany)
SP-0470